PRECEDE BIO Trademark

Trademark Overview

On Thursday, March 3, 2022, a trademark application was filed for PRECEDE BIO with the United States Patent and Trademark Office. The USPTO has given the PRECEDE BIO trademark a serial number of 97976132. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, July 21, 2025. This trademark is owned by Nuscan Diagnostics, Inc.. The PRECEDE BIO trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

diagnostic assays and reagents for clinical and medical use, namely, for the testing of body fluids; diagnostic chemical, biochemical and biological preparations for medical purposes, namely, for treating and preventing cancers and other clinical pathologies; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers

testing instruments for medical diagnostic purposes, namely, instruments for medical diagnostic testing in the fields of cancer; medical devices, namely, automated medical diagnostic image analyzers featuring a system consisting of computer hardware and software as a component of the medical devices, for use in detecting epigenetic signatures in the field of clinical pathology; diagnostic test kits consisting primarily of probes, buffer and reagents for use in microbial testing
precede bio

General Information

Serial Number97976132
Word MarkPRECEDE BIO
Filing DateThursday, March 3, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, July 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2024

Trademark Statements

Goods and Servicesdiagnostic assays and reagents for clinical and medical use, namely, for the testing of body fluids; diagnostic chemical, biochemical and biological preparations for medical purposes, namely, for treating and preventing cancers and other clinical pathologies; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers
NOT AVAILABLE"BIO"
Goods and Servicestesting instruments for medical diagnostic purposes, namely, instruments for medical diagnostic testing in the fields of cancer; medical devices, namely, automated medical diagnostic image analyzers featuring a system consisting of computer hardware and software as a component of the medical devices, for use in detecting epigenetic signatures in the field of clinical pathology; diagnostic test kits consisting primarily of probes, buffer and reagents for use in microbial testing

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, March 8, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePRECEDE BIOSCIENCES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NamePRECEDE BIOSCIENCES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameNuscan Diagnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Monday, March 7, 2022NEW APPLICATION ENTERED
Tuesday, March 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 29, 2022ASSIGNED TO EXAMINER
Tuesday, August 30, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 30, 2022NON-FINAL ACTION E-MAILED
Wednesday, February 8, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 28, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 2, 2023NON-FINAL ACTION WRITTEN
Thursday, March 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 2, 2023NON-FINAL ACTION E-MAILED
Tuesday, May 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 30, 2023DIVISIONAL REQUEST RECEIVED
Tuesday, May 30, 2023TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, May 31, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 25, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 26, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, July 27, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, July 27, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, July 27, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 27, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, July 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 15, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, August 21, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, August 23, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 23, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, August 23, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 23, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, January 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 6, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 6, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 23, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 13, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, August 22, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, October 1, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 15, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 21, 2025SOU EXTENSION 1 GRANTED
Tuesday, July 22, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 27, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, March 26, 2025SOU EXTENSION 1 FILED

Related Keywords

precede medical diagnostic testing namely clinical reagents instruments cancers test purposes